1991
DOI: 10.1182/blood.v78.1.55.55
|View full text |Cite
|
Sign up to set email alerts
|

Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1

Abstract: Murine IgM monoclonal antibody STRO-1 identifies a cell surface antigen expressed by stromal elements in human bone marrow (BM). STRO-1 binds to approximately 10% of BM mononuclear cells, greater than 95% of which are nucleated erythroid precursors, but does not react with committed progenitor cells (colony-forming unit granulocyte-macrophage [CFU-GM], erythroid bursts [BFU-E], and mixed colonies [CFU-Mix]). Fibroblast colony-forming cells (CFU-F) are present exclusively in the STRO-1+ population. Dual-color c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

16
485
1
5

Year Published

1994
1994
2017
2017

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 1,028 publications
(507 citation statements)
references
References 17 publications
16
485
1
5
Order By: Relevance
“…Consistently, they do not express marrow stromal cell marker STRO-1 and CD105 (Fig. 4), probably distinct from reported marrow stromal cell lines (Kawano et al 2003;Simmons and Torok-Storb, 1991). As expected, the FBMOB-hTERT can dramatically expand CB HSCs/HPCs ex vivo, especially maintaining HSC properties in vitro at least for 8 weeks.…”
Section: Discussionmentioning
confidence: 99%
“…Consistently, they do not express marrow stromal cell marker STRO-1 and CD105 (Fig. 4), probably distinct from reported marrow stromal cell lines (Kawano et al 2003;Simmons and Torok-Storb, 1991). As expected, the FBMOB-hTERT can dramatically expand CB HSCs/HPCs ex vivo, especially maintaining HSC properties in vitro at least for 8 weeks.…”
Section: Discussionmentioning
confidence: 99%
“…In the near future it will be interesting to investigate whether a subset of circulating CD34 progenitor cells expresses the STRO-1 surface antigen which identifies stromal precursors (Simmons & Torok-Storb, 1991a, b) and to identify the role of the CD34 /STRO-1 subset in osteoclast generation in vitro. Osteoclasts were observed from day 10 to day 14 of culture, when the maturation of the monocyte/macrophage progeny was still incomplete.…”
Section: Discussionmentioning
confidence: 99%
“…In this respect, one attempt to standardize the phenotypic characterization of MSCs came from the International Society for Cellular bs_bs_banner Clinical and Experimental Immunology ORIGINAL ARTICLE doi: 10.1111/cei.12270 Therapy (ISCT). The ISCT proposed that MSC populations must be positive for at least the following surface markers: cluster of differentiation (CD)44, CD73, CD90 and CD105 [17][18][19][20][21]. Additionally, these cells should lack the expression of haematopoietic antigens such as CD34 and CD45, as well as markers for monocytes, macrophages and B cells [21].…”
Section: Introductionmentioning
confidence: 99%